Atlas Trials

To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure

Clinical trial NCT02691533 · COMPLETED

Trial details

NCT number
NCT02691533
Sponsor
Institute of Liver and Biliary Sciences, India
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Liver Failure
Start date
2016-02-01
Primary completion
2017-12-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.